HaemoCer™ PLUS Absorbable Polysaccharide Haemostat (APH) is a proprietary patent pending technology based on BioCers Polysacharide Ultra-hydrophilic Resorbable Engineering (PURE) process.
HaemoCer™ PLUS APH incorporates a sophisticated, plant-based polymer crosslinking that creates ultra-hydrophilic, biocompatible particles. Once in contact with blood, HaemoCer™ PLUS enhances the natural clotting cascade by rapidly dehydrating the blood and accelerating the concentration of platelets, red blood cells and coagulation proteins at the bleeding site. The second mode of action of HaemoCer™ PLUS is the formation of a robust gelled matrix that adheres to the bleeding site and forms a mechanical barrier to prevent further bleeding.
Latest studies demonstrate that plant based haemostatic materials (polysaccharides) like HaemoCer™ PLUS also reduce postoperative adhesions.
HaemoCer™ PLUS is rapidly resorbed by amylase within 48h without leaving any residues behind.